Mutations in parkin are known to contribute to PD pathogenesis, as they lead to the degradation of Micro1, a parkin substrate involved in maintaining cytosolic calcium levels and promoting mitochondrial clearance. This evidence concerns the gene PRKN and Parkinson disease.